Wayne, NJ, United States of America

Manisha P Desai

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manisha P Desai: Innovator in Protein Formulations

Introduction

Manisha P Desai is a prominent inventor based in Wayne, NJ (US). She has made significant contributions to the field of protein formulations, particularly in the development of stable subcutaneous protein formulations. Her work is crucial for advancing treatments for immune system diseases.

Latest Patents

Manisha holds a patent for "Stable subcutaneous protein formulations and uses thereof." This invention relates to stable formulations comprising CTLA4Ig molecules, including both lyophilized and liquid formulations. These formulations are designed for administration via various routes, such as intravenous (IV) and subcutaneous (SC), aimed at treating immune system diseases and facilitating tolerance induction. She has 1 patent to her name.

Career Highlights

Manisha is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical company. Her role involves extensive research and development in the area of protein formulations, contributing to innovative solutions in healthcare.

Collaborations

Throughout her career, Manisha has collaborated with notable colleagues, including Sunita Borsadia and Rajesh Babulal Gandhi. These collaborations have enhanced her research and expanded the impact of her inventions.

Conclusion

Manisha P Desai is a trailblazer in the field of protein formulations, with her innovative patent contributing to advancements in medical treatments. Her work exemplifies the importance of research and collaboration in driving healthcare innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…